SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-001517
Filing Date
2023-01-04
Accepted
2023-01-04 16:25:11
Documents
18
Period of Report
2023-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d441188d8k.htm   iXBRL 8-K 40185
2 EX-4.1 d441188dex41.htm EX-4.1 88304
3 EX-10.1 d441188dex101.htm EX-10.1 262546
4 EX-10.2 d441188dex102.htm EX-10.2 99841
5 EX-99.1 d441188dex991.htm EX-99.1 10656
10 GRAPHIC g441188g0103092203607.jpg GRAPHIC 2640
  Complete submission text file 0001193125-23-001517.txt   774126

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmra-20230102.xsd EX-101.SCH 3897
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20230102_def.xml EX-101.DEF 14071
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20230102_lab.xml EX-101.LAB 23306
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20230102_pre.xml EX-101.PRE 15104
12 EXTRACTED XBRL INSTANCE DOCUMENT d441188d8k_htm.xml XML 5281
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 23506820
SIC: 2834 Pharmaceutical Preparations